Convalescence: Clinical Trials

1 trial for Convalescence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Convalescence: new trials by email Literature Review of Convalescence trials Research Report on Convalescence

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Convalescent Plasma to Stem Coronavirus (CSSC-001)
Anti- SARS-CoV-2 Plasma, SARS-CoV-2 non-immune Plasma - Coronavirus, Convalescence
Phase 2CompletedJohns Hopkins University1802020-06-102022-04-26

Narrower conditions

COVID-19 (1)  ·  Coronavirus Infections (1)

Broader conditions

Coronaviridae Infections (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Sponsors

Johns Hopkins University (1)

Countries

United States (1)

Top investigators

Shmuel Shoham, MD (1)

Results publications

PMID 34931202, PMID 35579509